Ratios

		vs industry	vs history
P/E(ttm)	18.70	STJ's P/E(ttm) is ranked higher than 82% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 24.10 vs. STJ: 18.70 )	STJ' s 10-Year P/E(ttm) Range Min: 12.71   Max: 78.55 Current: 18.7 12.71 78.55
P/B	3.25	STJ's P/B is ranked lower than 59% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.99 vs. STJ: 3.25 )	STJ' s 10-Year P/B Range Min: 2.13   Max: 8.61 Current: 3.25 2.13 8.61
P/S	2.65	STJ's P/S is ranked lower than 62% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.70 vs. STJ: 2.65 )	STJ' s 10-Year P/S Range Min: 1.84   Max: 7.3 Current: 2.65 1.84 7.3
PFCF	14.46	STJ's PFCF is ranked higher than 75% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 18.60 vs. STJ: 14.46 )	STJ' s 10-Year PFCF Range Min: 9.89   Max: 60.36 Current: 14.46 9.89 60.36
EV-to-EBIT	14.16	STJ's EV-to-EBIT is ranked higher than 72% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 16.25 vs. STJ: 14.16 )	STJ' s 10-Year EV-to-EBIT Range Min: 10   Max: 34.3 Current: 14.16 10 34.3
PEG	1.36	STJ's PEG is ranked higher than 97% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.23 vs. STJ: 1.36 )	STJ' s 10-Year PEG Range Min: 0.72   Max: 3.29 Current: 1.36 0.72 3.29
Shiller P/E	20.57	STJ's Shiller P/E is ranked higher than 90% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 23.60 vs. STJ: 20.57 )	STJ' s 10-Year Shiller P/E Range Min: 14.36   Max: 71.79 Current: 20.57 14.36 71.79

Dividend & Buy Back

		vs industry	vs history
Dividend Yield	2.00	STJ's Dividend Yield is ranked higher than 88% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.71 vs. STJ: 2.00 )	STJ' s 10-Year Dividend Yield Range Min: 0.39   Max: 2.81 Current: 2 0.39 2.81
Dividend Payout	0.4	STJ's Dividend Payout is ranked higher than 91% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 0.55 vs. STJ: 0.4 )	STJ' s 10-Year Dividend Payout Range Min: 0.33   Max: 0.39 Current: 0.4 0.33 0.39
Yield on cost (5-Year)	2.00	STJ's Yield on cost (5-Year) is ranked higher than 87% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.76 vs. STJ: 2.00 )	STJ' s 10-Year Yield on cost (5-Year) Range Min: 0.39   Max: 2.81 Current: 2 0.39 2.81
Share Buyback Rate	2.2	STJ's Share Buyback Rate is ranked higher than 93% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: -1.05 vs. STJ: 2.2 )	STJ' s 10-Year Share Buyback Rate Range Min: 2.2   Max: -1.9 Current: 2.2

Valuation & Return

		vs industry	vs history
Price/Net Current Asset Value	10.2	STJ's Price/Net Current Asset Value is ranked higher than 74% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 8.90 vs. STJ: 10.2 )	STJ' s 10-Year Price/Net Current Asset Value Range Min: 8.4   Max: 24.4 Current: 10.2 8.4 24.4
Price/Tangible Book	40.2	STJ's Price/Tangible Book is ranked higher than 93% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.80 vs. STJ: 40.2 )	STJ' s 10-Year Price/Tangible Book Range Min: 6.3   Max: 34.4 Current: 40.2 6.3 34.4
Price/DCF (Projected)	1.1	STJ's Price/DCF (Projected) is ranked higher than 79% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.25 vs. STJ: 1.1 )	STJ' s 10-Year Price/DCF (Projected) Range Min: 0.9   Max: 2.7 Current: 1.1 0.9 2.7
Price/Median PS Value	0.6	STJ's Price/Median PS Value is ranked higher than 52% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 0.80 vs. STJ: 0.6 )	STJ' s 10-Year Price/Median PS Value Range Min: 0.5   Max: 1.7 Current: 0.6 0.5 1.7
Price/Peter Lynch Fair Value	1.4	STJ's Price/Peter Lynch Fair Value is ranked higher than 92% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 2.10 vs. STJ: 1.4 )	STJ' s 10-Year Price/Peter Lynch Fair Value Range Min: 0.9   Max: 2.6 Current: 1.4 0.9 2.6
Price/Graham Number	5.6	STJ's Price/Graham Number is ranked higher than 90% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 1.80 vs. STJ: 5.6 )	STJ' s 10-Year Price/Graham Number Range Min: 2.7   Max: 7.8 Current: 5.6 2.7 7.8
Earnings Yield (Greenblatt)	7.10	STJ's Earnings Yield (Greenblatt) is ranked higher than 82% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 5.95 vs. STJ: 7.10 )	STJ' s 10-Year Earnings Yield (Greenblatt) Range Min: 2.9   Max: 10 Current: 7.1 2.9 10
Forward Rate of Return (Yacktman)	16.28	STJ's Forward Rate of Return (Yacktman) is ranked higher than 93% of the 165 Companies in the Global Medical Devices industry. ( Industry Median: 3.03 vs. STJ: 16.28 )	STJ' s 10-Year Forward Rate of Return (Yacktman) Range Min: 13   Max: 24.4 Current: 16.28 13 24.4

Business Description

St. Jude Medical, Inc. was incorporated in Minnesota in 1976. The Company develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's four operating segments are Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation (NMD). Its CV operating segment focuses on both the cardiology and cardiac surgery therapy areas. Its main products in each operating segment are as follows: CRM - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); CV - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; AF - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems; and NMD - neurostimulation products, which include spinal cord and deep brain stimulation devices. The Company markets and sells its products through both a direct sales force and independent distributors. The main geographic markets for its products are the United States, Europe, Japan and Asia Pacific. The Company's main competitors in this market are Medtronic, Inc. and Boston Scientific Corporation. These two competitors have invested substantial amounts in CRM research and development in a highly competitive market where rapid technological change is expected to continue, requiring the Company to invest heavily in R&D and effectively market its products. The Company's products, development activities and manufacturing processes are subject to extensive and rigorous regulation by the FDA pursuant to the Federal Food, Drug, and Cosmetic Act (FDCA), by comparable agencies in foreign countries and by other regulatory agencies and governing bodies.
Company Website
SEC Reports

Industry:	Medical Devices
Compare:	MDT, SYK, SMA, ZMH, EW
Traded in other countries:	JUD.Germany

» More Articles for STJ

Headlines

Articles On GuruFocus.com

Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys Feb 25 2013

20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013

Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012

My Best Healthcare Stock Picks For 2013 | Last Year’s Picks Gained 31.55% Dec 04 2012

Weekly CEO Sells Highlight: Entegris, Honeywell International, St Jude Medical and Wesco Internation Nov 05 2012

My 5 Favorite Health Care Growth Picks of the Next 5 Years Nov 02 2012

Six Stocks Will Benefit If Mitt Romeny Wins Oct 08 2012

Medtronic (MDT) Dividend Stock Analysis 2012 Oct 05 2012

Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio May 03 2012

Medtronic - A 'Must Own' Stock for 2012 Mar 07 2012

Personalized Checklist